These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22500712)

  • 21. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.
    Rogers SL; Farlow MR; Doody RS; Mohs R; Friedhoff LT
    Neurology; 1998 Jan; 50(1):136-45. PubMed ID: 9443470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donepezil for mild cognitive impairment.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006104. PubMed ID: 16856114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial.
    Liu NY; Pei H; Liu MX; Liu LT; Fu CG; Li H; Chen KJ
    Chin J Integr Med; 2020 Aug; 26(8):577-582. PubMed ID: 32761337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S; Feldman H; Hecker J; Vellas B; Emir B; Subbiah P;
    Curr Med Res Opin; 2002; 18(6):347-54. PubMed ID: 12442882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
    Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
    Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
    Dubois B; Tolosa E; Katzenschlager R; Emre M; Lees AJ; Schumann G; Pourcher E; Gray J; Thomas G; Swartz J; Hsu T; Moline ML
    Mov Disord; 2012 Sep; 27(10):1230-8. PubMed ID: 22915447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C; Oremus M; Shukla V; Momoli F; Demers L; Perrault A; Moride Y
    Clin Ther; 2002 Jun; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study.
    Maher-Edwards G; Dixon R; Hunter J; Gold M; Hopton G; Jacobs G; Hunter J; Williams P
    Int J Geriatr Psychiatry; 2011 May; 26(5):536-44. PubMed ID: 20872778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.
    Jia J; Wei C; Jia L; Tang Y; Liang J; Zhou A; Li F; Shi L; Doody RS
    J Alzheimers Dis; 2017; 56(4):1495-1504. PubMed ID: 28157100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study.
    Moraes W; Poyares D; Sukys-Claudino L; Guilleminault C; Tufik S
    Chest; 2008 Mar; 133(3):677-83. PubMed ID: 18198262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
    Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
    BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
    Rogers SL
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment.
    Zhang J; Yang C; Wei D; Li H; Leung EL; Deng Q; Liu Z; Fan XX; Zhang Z
    Pharmacol Res; 2019 Aug; 146():104319. PubMed ID: 31220560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study.
    Rogers SL; Doody RS; Pratt RD; Ieni JR
    Eur Neuropsychopharmacol; 2000 May; 10(3):195-203. PubMed ID: 10793322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.
    Feldman H; Gauthier S; Hecker J; Vellas B; Subbiah P; Whalen E;
    Neurology; 2001 Aug; 57(4):613-20. PubMed ID: 11524468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.